Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

RSV vaccine study: do nursing home residents get the same protection?

NCT ID NCT06077149

First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 25 times

Summary

This study looked at how well licensed RSV vaccines work in adults over 60 living in long-term care facilities compared to those living independently in the community. Researchers measured immune responses in 152 participants to see if the vaccines provide similar protection for both groups. The goal is to ensure older adults in nursing homes are adequately protected against RSV.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS (RSV) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Rochester Medical Center

    Rochester, New York, 14642, United States

Conditions

Explore the condition pages connected to this study.